AROMASIN

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Ecuador, Estonia, Finland, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Nigeria, Romania, Singapore, South Africa, Turkey, UK.

Active ingredients

The drug AROMASIN contains one active pharmaceutical ingredient (API):

1	Exemestane UNII NY22HMQ4BX - EXEMESTANE
	Exemestane is an irreversible, steroidal aromatase inhibitor, structurally related to the natural substrate androstenedione.
	Read more about Exemestane

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
AROMASIN Coated tablets	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L02BG06	Exemestane	L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02B Hormone antagonists and related agents → L02BG Aromatase inhibitors
Discover more medicines within L02BG06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10103R, 8506Q
BR	Câmara de Regulação do Mercado de Medicamentos	522718030074417
CA	Health Products and Food Branch	02242705
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00361689, 00706384, 00706409, 07639343, 07639366, 09000817, 09155046, 10941910
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	30067-12-11
EE	Ravimiamet	1011148
FI	Lääkealan turvallisuus- ja kehittämiskeskus	161547
GB	Medicines & Healthcare Products Regulatory Agency	26698, 299778, 373745
HK	Department of Health Drug Office	46969
HR	Agencija za lijekove i medicinske proizvode	HR-H-093797365
IE	Health Products Regulatory Authority	13710, 13712, 13726, 62894
IL	מִשְׂרַד הַבְּרִיאוּת	4011
IT	Agenzia del Farmaco	034678033, 045700010
JP	医薬品医療機器総合機構	4291012F1022
LT	Valstybinė vaistų kontrolės tarnyba	1004069
MT	Medicines Authority	MA505/02801
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	185M2000
NG	Registered Drug Product Database	04-9994
Switch country to Nigeria in order to find specific presentations of AROMASIN
NL	Z-Index G-Standaard, PRK	54917
NZ	Medicines and Medical Devices Safety Authority	9445
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65092001
SG	Health Sciences Authority	11398P
TR	İlaç ve Tıbbi Cihaz Kurumu	8681308121004
US	FDA, National Drug Code	0009-7663
ZA	Health Products Regulatory Authority	35/21.12/0011